samedan logo
 
 
 
spacer
home > ebr > spring 2008 > twenty-first century recruits
PUBLICATIONS
European Biopharmaceutical Review

Twenty-First Century Recruits

Talent acquisition today poses numerous challenges and opportunities for the life sciences industry. Pete Leddy of Invitrogen explores the changing world of pharmaceutical recruitment

Recruiting and retaining top employees is critical in order to secure a company’s continued success. As the biotechnology industry grows and expands, its talent needs rapidly increase, while the pool of qualified, diverse applicants is shrinking. This article explores the overall environment for talent acquisition (TA) in the life sciences and discusses why a solid TA plan is essential to achieving business goals. It will focus on a few of the challenges and experiences faced by the industry over the next few years, and will outline the resources that companies have at their disposal to attract and retain top talent.

BUSINESS GOALS IN THE SHORT AND LONG TERM

In developing a talent acquisition plan, companies must examine both long- and short-term business goals in order to align any hiring with those goals. What must a company accomplish in order to grow? The answer to that question will evidently vary significantly from company to company. Biotechnology and pharmaceutical companies poised to enter the clinic must be adept at planning clinical trials and working with regulatory agencies such as the US Food and Drug Administration (FDA) or the European Medicines Agency (EMEA). On the other hand, biotechnology tools companies seeking to offer ever more advanced technologies to life sciences researchers must continue to invest in newer technologies and build strong infrastructures to meet the demands of their customers.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Pete Leddy is Senior Vice President of Human Resources for Invitrogen, where he oversees global HR strategy and manages all aspects of the field. Prior to joining Invitrogen in 2005, Pete served as Vice President of Human Resources for the Americas operations of Dell Incorporated. He holds a PhD and a Master of Science degree in Industrial Organizational Psychology from the Illinois Institute of Technology.
spacer
Pete Leddy
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Over 300 Clinical Studies Benefit from CluePoints COVID-19 Risk Management Support

CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced the success of its complimentary COVID-19 risk management package alongside comprehensive support for COVID-19 affected trials.
More info >>

White Papers

EU GDP Guidelines: Implications for Shipping Clinical Materials into the European Market

PCI Pharma Services

Recently, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) opened an investigation into a patient complaint of mold on paracetamol (acetaminophen) tablets (1). It discovered the product was shipped by sea from India to multiple companies in the UK at temperatures reaching up to 60 degrees Celsius. Labeling for paracetamol tablets typically states they should be kept below 30 degrees Celsius. In addition, MHRA discovered the humidity levels exceeded 80 percent during shipping, which is too high for the packaging that was used.
More info >>

 
Industry Events

CPhI Festival of Pharma

5-16 October 2020, Virtual

A virtual gathering for the pharmaceutical industry, the CPhI Festival of Pharma has been created to fill the gap left by in-person events at a time when travel and gatherings are off the cards.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement